Innovative Home Monitoring StethoMe® offers a unique, AI-powered home lung monitoring device tailored for parents managing their children's asthma, presenting opportunities to partner with healthcare providers, telemedicine platforms, and pharmacy chains to expand its reach.

Growing Market Presence Having secured $2.5 million in financing and launched its wireless stethoscope, StethoMe® is poised to increase its footprint in the European telemedicine and pediatric health markets, which could open avenues for regional expansion and new distribution channels.

FDA & CE Certification With its EU CE 2274 certification for medical device safety, StethoMe® demonstrates compliance with stringent medical standards, making it a trusted option for medical institutions and a potential partner for clinical collaborations and B2B sales.

Technology & Integration Leveraging AI, telemedicine, and IoT-enabled hardware, StethoMe®’s technology stack is compatible with broader digital health ecosystems, providing potential for integration with electronic health records and insurance-related health monitoring solutions.

Small Yet Nimble As a relatively small company with 11-50 employees and revenue under 1 million USD, StethoMe® presents opportunities for strategic partnerships, pilot programs, and co-marketing initiatives to accelerate adoption and customer acquisition in targeted demographics.